Home > Insider Trading > Filing (0001140361-11-000903)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880643	Genta Inc De	GNTA	Biological Products, (No Disgnostic Substances) (2836)	330326866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1100843	Jr P Raymond Warrell	C/O Genta Incorporated 200 Connell Drive Berkeley Heights NJ 07922	Chairman & Chief Exec Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-12-31	688,762	$0.04	558,486,989	No	4	C	Direct
Common Stock	Disposition	2010-12-31	699,422	$0.03	557,787,567	No	4	S	Direct
Common Stock	Acquisiton	2011-01-03	2,215,946	$0.00	557,787,567	No	4	C	Direct
Common Stock	Disposition	2011-01-03	2,215,946	$0.02	555,571,620	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	S	Direct
No	4	C	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	15% Senior Convertible Promissory Note due September 4, 2011	Disposition	2010-12-31	0	$0.00	688,762	$0.04
Common Stock	15% Senior Convertible Promissory Note due September 4, 2011	Disposition	2011-01-03	0	$0.00	2,215,946	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,782,460	2008-10-07	2011-09-04	No	4	C	Direct
1,765,665	2008-10-07	2011-09-04	No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,829,644	Indirect	By Spouse

Footnotes

Includes 699,422 shares of common stock held in a joint account with Dr. Warrell's spouse, Dr. Itri, 768,817 shares of common stock issuable upon the vesting of currently outstanding restricted stock units, 553,986,250 shares of common stock issuable upon the conversion of Senior Unsecured Convertible Promissory Notes due September 4, 2011, as amended, (the Notes) at the conversion price of $0.0032 that went into effect on January 1, 2011 and 3,032,500 shares of common stock issuable upon the conversion of Notes held by Dr. Warrell's IRA.
Includes 280,894 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units held by Dr. Itri and 4,548,750 shares of common stock issuable upon the conversion of Notes held in Dr. Itri's IRA.